Staffanstorp, Sweden

Bengt Erik Kjellberg


Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1977-1982

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Bengt Erik Kjellberg

Introduction

Bengt Erik Kjellberg is a notable inventor based in Staffanstorp, Sweden. He has made significant contributions to the field of pharmaceuticals, holding a total of four patents. His work primarily focuses on compounds that are active in the central nervous system, showcasing his expertise in medicinal chemistry.

Latest Patents

Kjellberg's latest patents include innovative compounds such as aryl ethers of N-alkyl-piperidines and acid addition salts thereof. These compounds feature various substituents, including hydrogen, halogen, and lower alkanoyl groups, which enhance their pharmaceutical properties. Another notable patent involves diarylbutyl octahydropyrazinopyrimidinones, which are also designed for medical applications. These inventions highlight his commitment to advancing medical treatments through chemical innovation.

Career Highlights

Throughout his career, Kjellberg has been associated with Ab Ferrosan, a company known for its focus on pharmaceutical development. His work has contributed to the creation of effective medical treatments, demonstrating his impact on the industry.

Collaborations

Kjellberg has collaborated with esteemed colleagues such as Anders K Bjork and Sven E Hernestam. These partnerships have likely enriched his research and development efforts, leading to successful innovations in the pharmaceutical field.

Conclusion

Bengt Erik Kjellberg's contributions to pharmaceutical inventions underscore his role as a significant inventor in the industry. His patents reflect a dedication to improving medical treatments and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…